Skip to content
Clinical Trials – home
The NetherlandsBack to the Netherlands

Clinical trials in Haarlem – page 3

29 clinical trials in Haarlem, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.

The NetherlandsOur site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
Haarlem at a glance
29
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

29 trials in Haarlem

Open in trial search
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Atrial fibrillation+2

Not recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Pneumonia+2

Not recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Amsterdam UMC
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years
  • Substances:Oxygen
  • Sponsor:Spaarne Gasthuis

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Haarlem

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials exploring treatments for heart failure prevention and management of cardiovascular diseases. Studies include evaluation of new medications for reducing cardiac events and improving outcomes in patients with established heart conditions.

  • Heart Failure Prevention
  • Atrial Fibrillation Management
  • Cardiovascular Risk Reduction

Advanced research combining established treatments with novel therapeutic approaches to enhance cardiovascular health outcomes.

02 Metabolic Disorders

Comprehensive studies addressing Type 2 Diabetes and obesity, investigating innovative treatments and their impact on cardiovascular outcomes. Research focuses on testing new therapeutic agents for improved metabolic control.

  • Obesity Management
  • Diabetes Treatment
  • Metabolic Health

Integration of novel therapeutic approaches with established treatments for better metabolic disease management.

03 Neurological Studies

Research initiatives examining treatments for multiple sclerosis and stroke prevention. Studies include personalized dosing strategies and evaluation of antiplatelet therapy effectiveness in young stroke patients.

  • Multiple Sclerosis Treatment
  • Stroke Prevention
  • Dementia Management

Focus on developing targeted therapies and optimizing treatment protocols for neurological conditions.

04 Oncology Research

Studies investigating treatments for various cancers, including colorectal liver metastases and esophageal adenocarcinoma. Research includes evaluation of targeted therapies and combination treatment approaches.

  • Colorectal Cancer
  • Esophageal Cancer
  • Cancer Prevention

Development of innovative therapeutic strategies to improve cancer treatment outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.